Home › Funds › BRADLEY FOSTER & SARGENT INC/CT › JNJ

BRADLEY FOSTER & SARGENT INC/CT position in JNJ

JOHNSON & JOHNSON · Health Care

BRADLEY FOSTER & SARGENT INC/CT reported holding 320,528 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$84.9M, representing 1.21% of its reported portfolio and ranking #21 among its reported holdings. BRADLEY FOSTER & SARGENT INC/CT has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)320.53K sh
Reported value held$84.86M
Portfolio Weight1.21%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How BRADLEY FOSTER & SARGENT INC/CT's JNJ position evolved

BRADLEY FOSTER & SARGENT INC/CT first disclosed a stake in JNJ in Q3 2023 at 432,884 shares (US$71.7M). The position peaked in Q3 2026 at 320,528 shares, worth US$84.9M. Across 13 filings, BRADLEY FOSTER & SARGENT INC/CT increased the stake 0 time(s), trimmed it 10 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 320,528 shares valued at US$84.9M — a reduction of -13,378 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 432.88K $71.65M New
Q4 2023 411.39K $64.48M Reduce
Q1 2024 396.49K $62.72M Reduce
Q2 2024 395.40K $57.79M Hold
Q3 2024 391.72K $63.48M Reduce
Q4 2024 382.91K $55.38M Reduce
Q1 2025 374.33K $62.08M Reduce
Q2 2025 349.51K $53.39M Reduce
Q3 2025 341.51K $63.32M Reduce
Q4 2025 338.68K $70.09M Reduce
Q1 2026 334.99K $81.89M Reduce
Q2 2026 333.91K $84.80M Hold
Q3 2026 320.53K $84.86M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$55.52B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has BRADLEY FOSTER & SARGENT INC/CT held JNJ?

BRADLEY FOSTER & SARGENT INC/CT has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is BRADLEY FOSTER & SARGENT INC/CT's current position in JNJ?

As of Q3 2026, BRADLEY FOSTER & SARGENT INC/CT holds 320.53K shares of JNJ (JOHNSON & JOHNSON), valued at $84.86M, representing 1.21% of its reported portfolio and ranking #21.

Has BRADLEY FOSTER & SARGENT INC/CT been buying or selling JNJ?

In the latest 13F filing (Q3 2026), BRADLEY FOSTER & SARGENT INC/CT reduced its position in JNJ. The position peaked in Q3 2026 at 320.53K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.